Showing results (521-530 of 2,122) with videos related to
Sort By:
Pageof 213
Journal of Ovarian Research|June 27, 2026
Epigenetic safety of in vitro maturation in PCOS: genome-wide DNA methylation profiling of cord blood from a randomized controlled trialWei Guo, Yi Yang, Meng Qin, et al.Journal of Ovarian Research|July 2, 2026
Exploring the role of the NLRP3 Inflammasome in polycystic ovary syndrome: therapeutic potential of herbal medicinesShayan Vafaei, Reyhane Naghibzade, Ghazaleh Moshkdanian, et al.Journal of Ovarian Research|July 3, 2026
Melatonin in ovarian function and dysfunction: Molecular mechanisms and therapeutic potentialXuanrui Zhao, Yan Zhang, Kaixin Ding, et al.Journal of Ovarian Research|July 16, 2026
Spontaneous natural conception and live birth in three patients with likely pathogenic variants in TUBB8, ZP2, and ZP3 associated with female subfertilityJuepu Zhou, Hui He, Ruolin Mao, et al.Journal of Ovarian Research|July 18, 2026
Multi-omics analysis reveals the effects of Jinfeng pills on the outcomes of IVF-ET in patients with poor ovarian response: a randomized controlled trialXumei Kong, Qianwen Luo, Tianhong Huang, et al.Journal of Ovarian Research|July 21, 2026
Cyclophosphamide-induced animal models of ovarian dysfunction: from molecular mechanisms and modeling strategies to validation criteriaYanxi Wang, Jixing Cao, Zheng Gong, et al.Journal of Ovarian Research|December 24, 2010
Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumorsKrishna Penumatsa, Seby L Edassery, Animesh Barua, et al.Journal of Ovarian Research|March 1, 2011
Hematopoietic-Prostaglandin D2 synthase through PGD2 production is involved in the adult ovarian physiologyAndalib Farhat, Pascal Philibert, Charles Sultan, et al.Journal of Ovarian Research|July 29, 2010
Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metforminAngela Falbo, Morena Rocca, Tiziana Russo, et al.Journal of Ovarian Research|August 21, 2010
Augmented inhibition of angiogenesis by combination of HER2 antibody chA21 and trastuzumab in human ovarian carcinoma xenograftAnli Zhang, Guodong Shen, Ting Zhao, et al.Pageof 213